AnaMar Company

AnaMar developes first-in-class 5-HT2B receptor antagonists to create life-changing treatments of pathological fibrosis.
Industry: Small&Large Molecules
Headquarters: Skane Lan, Sweden
Visit Website
Register and Claim Ownership